1. Volume 14, Issue 8, Pages 1019-1027 (December 2011)
Cost-Effectiveness Analysis of a Universal Infant Immunization Program with Meningococcal C Conjugate Vaccine in Brazil 
Patricia Coelho de Soarez, MPH, PhD, Ana Marli C. Sartori, PhD, Laura de Andrade Lagoa Nóbrega, MD, Alexander Itria, MS, Hillegonda Maria Dutilh Novaes, PhD 
Value in Health 
Volume 14, Issue 8, Pages (December 2011)
DOI: /j.jval
Copyright © 2011 International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Terms and Conditions

2. Fig. 1
Simplified diagram of the decision tree model used to analyze the cost-effectiveness of a meningococcal C universal vaccination program in children younger than 1 year in Brazil.
Value in Health  , DOI: ( /j.jval )
Copyright © 2011 International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Terms and Conditions

3. Fig. 2
Results of a sensitivity analysis according to the parameter variation. The values for parameters are presented in Table 1. The Word Health Organization threshold value for cost-effectiveness suggests that interventions costing less than three gross domestic products (GDPs) per capita for each disability-adjusted life-year averted is a cost-effective intervention, and interventions costing les than one GDP per capita for each DALY averted is a very cost-effective intervention [32]. The 2006 Brazilian GDP per capita is R$12,688.
Value in Health  , DOI: ( /j.jval )
Copyright © 2011 International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Terms and Conditions

4. Fig. 3
The impact of the cost per vaccine dose on the incremental cost-effectiveness ratio per life-year saved from society's perspective. The Word Health Organization threshold value for cost-effectiveness suggests that an intervention costing less than three gross domestic products (GDPs) per capita for each disability-adjusted life-year averted is a cost-effective intervention, and an intervention costing less than one GDP per capita for each disability-adjusted life-year averted is a very cost-effective intervention [32]. The 2006 Brazilian GDP per capita is R$12,688.
Value in Health  , DOI: ( /j.jval )
Copyright © 2011 International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Terms and Conditions

5. Fig. 4
Cost-effectiveness acceptability curve for vaccination strategies.
Value in Health  , DOI: ( /j.jval )
Copyright © 2011 International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Terms and Conditions